000 | 01922 a2200505 4500 | ||
---|---|---|---|
005 | 20250516050520.0 | ||
264 | 0 | _c20111122 | |
008 | 201111s 0 0 eng d | ||
022 | _a1083-351X | ||
024 | 7 |
_a10.1074/jbc.M111.235606 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOkunishi, Katsuhide | |
245 | 0 | 0 |
_aPlasmin overcomes resistance to prostaglandin E2 in fibrotic lung fibroblasts by reorganizing protein kinase A signaling. _h[electronic resource] |
260 |
_bThe Journal of biological chemistry _cSep 2011 |
||
300 |
_a32231-43 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aA Kinase Anchor Proteins _xgenetics |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xadverse effects |
650 | 0 | 4 |
_aBleomycin _xadverse effects |
650 | 0 | 4 |
_aCell Nucleus _xgenetics |
650 | 0 | 4 |
_aCyclic AMP _xgenetics |
650 | 0 | 4 |
_aCyclic AMP-Dependent Protein Kinases _xgenetics |
650 | 0 | 4 |
_aCytoskeletal Proteins _xgenetics |
650 | 0 | 4 |
_aDinoprostone _xpharmacology |
650 | 0 | 4 |
_aDrug Resistance _xdrug effects |
650 | 0 | 4 |
_aFibrinolysin _xgenetics |
650 | 0 | 4 |
_aFibroblasts _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLung _xmetabolism |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 |
_aMicrotubule-Associated Proteins _xgenetics |
650 | 0 | 4 |
_aOxytocics _xpharmacology |
650 | 0 | 4 |
_aProtein Phosphatase 2 _xgenetics |
650 | 0 | 4 |
_aPulmonary Fibrosis _xchemically induced |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
700 | 1 | _aSisson, Thomas H | |
700 | 1 | _aHuang, Steven K | |
700 | 1 | _aHogaboam, Cory M | |
700 | 1 | _aSimon, Richard H | |
700 | 1 | _aPeters-Golden, Marc | |
773 | 0 |
_tThe Journal of biological chemistry _gvol. 286 _gno. 37 _gp. 32231-43 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1074/jbc.M111.235606 _zAvailable from publisher's website |
999 |
_c21041745 _d21041745 |